3 Firms Seek To Rep Biogen Investors In Securities Fraud Suit

By Emilie Ruscoe (January 13, 2021, 11:25 PM EST) -- The Rosen Law Firm PA, Lowey Dannenberg PC and Pomerantz LLP all want to represent a proposed class of investors in a securities fraud suit in California federal court alleging Biogen Inc. and three of its executives misrepresented the odds of success that one of the pharmaceutical company's drugs has with the U.S. Food and Drug Administration....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!